Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX)-a randomized phase II trial of the AIO pancreatic cancer group.

Autor: Seufferlein T; Department of Internal Medicine I, Ulm University, Ulm, Germany. Electronic address: thomas.seufferlein@uniklinik-ulm.de., Uhl W; Department of General and Visceral Surgery, St. Josef-Hospital Bochum, Ruhr-University Bochum, Bochum, Germany., Kornmann M; Department of General and Visceral Surgery, Ulm University, Ulm, Germany., Algül H; CCC Munich-TUM and Department of Internal Medicine II, TUM, Munich, Germany., Friess H; Department of General and Visceral Surgery, TUM, Munich, Germany., König A; Department of Gastroenterology, GI-Oncology and Endocrinology, University Medical Center, Göttingen, Germany., Ghadimi M; Department of General and Visceral Surgery, University Medical Center Göttingen, Göttingen, Germany., Gallmeier E; Department of Gastroenterology and Endocrinology, University of Marburg, Marburg, Germany., Bartsch DK; Department of General and Visceral Surgery, University of Marburg, Marburg, Germany., Lutz MP; Department of Gastroenterology, Caritasklinik St. Theresia, Saarbrücken, Germany., Metzger R; Department of General and Visceral Surgery, Caritasklinik St. Theresia, Saarbrücken, Germany., Wille K; Department of Hematology, Oncology, Hemostaseology and Palliative Care, Johannes Wesling Medical Center Minden, Ruhr-University Bochum, Bochum, Germany., Gerdes B; Department of General and Visceral Surgery Minden, Ruhr-University Bochum, Minden, Germany., Schimanski CC; Department of Internal Medicine and Gastroenterology, Darmstadt Hospital, Darmstadt, Germany., Graupe F; Department of General and Visceral Surgery, Darmstadt Hospital, Darmstadt, Germany., Kunzmann V; Department of Internal Medicine II, Julius Maximilians University, Würzburg, Germany., Klein I; Department of General, Visceral, Vascular and Pediatric Surgery, Julius Maximilians University, Würzburg, Germany., Geissler M; Department of Hematology and Oncology, Esslingen Hospital, Esslingen, Germany., Staib L; Department of Surgery, Esslingen Hospital, Esslingen, Germany., Waldschmidt D; Department of Gastroenterology and Hepatology, University of Cologne, Cologne, Germany., Bruns C; Department of Visceral Surgery, University of Cologne, Cologne, Germany., Wittel U; Department of General and Visceral Surgery, University of Freiburg, Freiburg, Germany., Fichtner-Feigl S; Department of General and Visceral Surgery, University of Freiburg, Freiburg, Germany., Daum S; Department for Gastroenterology, Rheumatology and Infectology, Charite University Hospital Berlin, Berlin, Germany., Hinke A; Biostatistics, CCRC Cancer Clinical Research Consulting, Düsseldorf, Germany., Blome L; Biometrics, ClinAssess Gesellschaft für klinische Forschung mbH, Leverkusen, Germany., Tannapfel A; Institute of Pathology, Ruhr-University Bochum, Bochum, Germany., Kleger A; Department of Internal Medicine I, Ulm University, Ulm, Germany., Berger AW; Department of Internal Medicine I, Ulm University, Ulm, Germany., Kestler AMR; Department of Internal Medicine I, Ulm University, Ulm, Germany., Schuhbaur JS; Department of Internal Medicine I, Ulm University, Ulm, Germany., Perkhofer L; Department of Internal Medicine I, Ulm University, Ulm, Germany., Tempero M; UCSF Department of Medicine, University of California San Francisco, San Francisco, USA., Reinacher-Schick AC; Department of Hematology, Oncology and Palliative Care, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany., Ettrich TJ; Department of Internal Medicine I, Ulm University, Ulm, Germany.

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2023 Jan; Vol. 34 (1), pp. 91-100. Date of Electronic Publication: 2022 Oct 07.

Comparison of treatment models for single primary advanced gallbladder cancer.

Autor: Li, Rongxuan, Chen, Xiao, Wang, Bingchen, Ai, Bolun, Min, Fangdi, Cao, Dayong, Zhou, Jianguo, Yan, Tao

Publikováno v: Frontiers in Immunology; 2024, p1-17, 17p

Matrine inhibits invasion and migration of gallbladder cancer via regulating the PI3K/AKT signaling pathway.

Autor: Mo RL; Anhui Medical University, School of Basic Medical Sciences, Hefei, 230032, China., Li Z; Department of General Surgery, The Chinese People's Armed Police Forces Anhui Provincial Corps Hospital, Hefei, 230041, China., Zhang P; Graduate School, Anhui University of Chinese Medicine, Hefei, 230022, China., Sheng MH; Department of General Surgery, The Chinese People's Armed Police Forces Anhui Provincial Corps Hospital, Hefei, 230041, China. shengmh17@163.com., Han GC; Anhui Medical University, School of Basic Medical Sciences, Hefei, 230032, China. genchenghan@163.com.; Beijing Institute of Basic Medical Sciences, Beijing, 100850, China. genchenghan@163.com., Sun DQ; Department of General Surgery, The Chinese People's Armed Police Forces Anhui Provincial Corps Hospital, Hefei, 230041, China. sundengqunsyl@126.com.

Publikováno v: Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2024 Oct; Vol. 397 (10), pp. 8129-8143. Date of Electronic Publication: 2024 May 25.

The ABCG8 polymorphism increases the risk of gallbladder cancer in the general population and gallstones in obese patients from Poland.

Autor: Krupa L; Department of Gastroenterology and Hepatology with Internal Disease Unit, Teaching Hospital No 1 in Rzeszów, Rzeszów, Poland.; Medical Department, University of Rzeszów, Rzeszów, Poland., Kalinowski P; Department of General, Transplant and Liver Surgery, Medical University of Warsaw, Warsaw, Poland., Ligocka J; Department of Gastroenterology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland., Dauer M; Department of Medicine II, Saarland University Medical Center, Saarland University, Homburg, Germany., Jankowski K; Department of Internal Medicine and Cardiology, Medical University of Warsaw, Warsaw, Poland.; Department of Social Medicine and Public Health, Medical University of Warsaw, Warsaw, Poland., Gozdowska J; Department of Transplantation Medicine and Nephrology, Medical University of Warsaw, Warsaw, Poland., Kruk B; Laboratory of Metabolic Liver Diseases, Department of General, Transplant and Liver Surgery, Medical University of Warsaw, Warsaw, Poland., Milkiewicz P; Translational Medicine Group, Pomeranian Medical University, Szczecin, Poland.; Liver and Internal Medicine Unit, Medical University of Warsaw, Warsaw, Poland., Zieniewicz K; Department of General, Transplant and Liver Surgery, Medical University of Warsaw, Warsaw, Poland., Krawczyk M; Department of General, Transplant and Liver Surgery, Medical University of Warsaw, Warsaw, Poland., Weber SN; Department of Medicine II, Saarland University Medical Center, Saarland University, Homburg, Germany., Lammert F; Hannover Medical School (MHH), Hannover, Germany., Krawczyk M; Department of Medicine II, Saarland University Medical Center, Saarland University, Homburg, Germany.; Laboratory of Metabolic Liver Diseases, Department of General, Transplant and Liver Surgery, Medical University of Warsaw, Warsaw, Poland.

Publikováno v: European journal of clinical investigation [Eur J Clin Invest] 2024 Aug; Vol. 54 (8), pp. e14213. Date of Electronic Publication: 2024 Apr 14.

FOXA2 suppresses gallbladder carcinoma cell migration, invasion, and epithelial-mesenchymal transition by targeting SERPINB5.

Autor: Hong L; Department of Hepatobiliary Surgery and Fujian Institute of Hepatobiliary Surgery, Fujian Medical University Union Hospital, Fujian Medical University, Fuzhou, China.; Fujian Medical University Cancer Center, Fujian Medical University, Fuzhou, China.; Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China.; Fujian Key Laboratory of Tumor Microbiology, Department of Medical Microbiology, Fujian Medical University, Fuzhou, China., Chen M; Department of Hepatobiliary Surgery and Fujian Institute of Hepatobiliary Surgery, Fujian Medical University Union Hospital, Fujian Medical University, Fuzhou, China.; Fujian Medical University Cancer Center, Fujian Medical University, Fuzhou, China.; Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China.; Fujian Key Laboratory of Tumor Microbiology, Department of Medical Microbiology, Fujian Medical University, Fuzhou, China., Huang M; Department of Hepatobiliary Surgery and Fujian Institute of Hepatobiliary Surgery, Fujian Medical University Union Hospital, Fujian Medical University, Fuzhou, China.; Fujian Medical University Cancer Center, Fujian Medical University, Fuzhou, China.; Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China.; Fujian Key Laboratory of Tumor Microbiology, Department of Medical Microbiology, Fujian Medical University, Fuzhou, China., Chen W; Department of Hepatobiliary Surgery and Fujian Institute of Hepatobiliary Surgery, Fujian Medical University Union Hospital, Fujian Medical University, Fuzhou, China.; Fujian Medical University Cancer Center, Fujian Medical University, Fuzhou, China.; Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China.; Fujian Key Laboratory of Tumor Microbiology, Department of Medical Microbiology, Fujian Medical University, Fuzhou, China., Abudukeremu X; Department of Hepatobiliary Surgery and Fujian Institute of Hepatobiliary Surgery, Fujian Medical University Union Hospital, Fujian Medical University, Fuzhou, China.; Fujian Medical University Cancer Center, Fujian Medical University, Fuzhou, China.; Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China.; Fujian Key Laboratory of Tumor Microbiology, Department of Medical Microbiology, Fujian Medical University, Fuzhou, China., She F; Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China.; Fujian Key Laboratory of Tumor Microbiology, Department of Medical Microbiology, Fujian Medical University, Fuzhou, China., Chen Y; Department of Hepatobiliary Surgery and Fujian Institute of Hepatobiliary Surgery, Fujian Medical University Union Hospital, Fujian Medical University, Fuzhou, China.; Fujian Medical University Cancer Center, Fujian Medical University, Fuzhou, China.; Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China.; Fujian Key Laboratory of Tumor Microbiology, Department of Medical Microbiology, Fujian Medical University, Fuzhou, China.

Publikováno v: Environmental toxicology [Environ Toxicol] 2024 Feb; Vol. 39 (2), pp. 708-722. Date of Electronic Publication: 2023 Sep 04.